Achieve Life Sciences Inc. (ACHV)
$5.29
$-0.50
(-8.64%)
As on 15-May-2026 16:19EDT
Market cap
$543 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
24.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-5 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-2.4
-
Debt to Equity
0
-
Book Value
$0.2
-
EPS
$-1.2
-
Face value
--
-
Shares outstanding
102,659,057
10 Years Aggregate
CFO
$-195.98 Mln
EBITDA
$-207.53 Mln
Net Profit
$-221.83 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
| 6.4 | 46.5 | 26.0 | 113.3 | -13.7 | -10.9 | -44.4 |
|
BSE Sensex*
| -11.1 | -4.0 | -9.7 | -8.5 | 7.0 | 8.7 | 11.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
| 41.2 | -14.5 | 68.2 | -68.5 | -4.0 | -23.6 | -56.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
5.3 | 543.1 | 0.0 | -52.0 | -- | -234.8 | -- | 24.9 |
| 76.7 | 10,799.5 | 622.0 | -300.9 | -30.1 | -62 | -- | 16.7 | |
| 240.5 | 14,858.0 | 867.5 | 506.6 | -2.8 | -- | 27.1 | 25.7 | |
| 75.9 | 10,298.2 | 105.8 | -829.6 | -715.0 | -- | -- | 60.3 | |
| 50.1 | 12,600.4 | 2,375.5 | 833.4 | 40.8 | 40.7 | 16.6 | 6.3 | |
| 94.9 | 12,586.4 | 1,080.2 | -433.2 | -39.8 | -- | -- | 55.7 | |
| 306.3 | 9,097.8 | 417.3 | 225.0 | 42.8 | 18.6 | 41.3 | 7.1 | |
| 523.7 | 12,074.0 | 1,132.5 | -309.4 | -25.5 | -52.9 | -- | 21.6 | |
| 415.3 | 11,860.0 | 2,678.3 | 460.4 | 21.1 | 103.2 | 26.1 | 20.2 | |
| 342.6 | 9,550.7 | 0.0 | -326.5 | -- | -37.2 | -- | 6.5 |
Shareholding Pattern
View DetailsAbout Achieve Life Sciences (ACHV)
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring... alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington. Read more
-
Executive Chairman
Dr. Richard A. B. Stewart
-
Executive Chairman
Mr. Thomas B. King M.B.A.
-
Headquarters
Bothell, WA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Achieve Life Sciences (ACHV)
What is the current share price of Achieve Life Sciences Inc (ACHV) Today?
The share price of Achieve Life Sciences Inc (ACHV) is $5.29 (NASDAQ) as of 15-May-2026 16:19 EDT. Achieve Life Sciences Inc (ACHV) has given a return of -13.66% in the last 3 years.
What is the current PB & PE ratio of Achieve Life Sciences Inc (ACHV)?
Since, TTM earnings of Achieve Life Sciences Inc (ACHV) is negative, P/E ratio is not available.
The P/B ratio of Achieve Life Sciences Inc (ACHV) is 24.86 times as on 15-May-2026, a 454 premium to its peers’ median range of 4.49 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-4.00
|
10.16
|
|
2024
|
-2.83
|
5.39
|
|
2023
|
-2.76
|
-56.91
|
|
2022
|
-0.64
|
3.25
|
|
2021
|
-1.89
|
2.22
|
What is the 52 Week High and Low of Achieve Life Sciences Inc (ACHV)?
The 52-week high and low of Achieve Life Sciences Inc (ACHV) are Rs 6.15 and Rs 2.00 as of 18-May-2026.
What is the market cap of Achieve Life Sciences Inc (ACHV)?
Achieve Life Sciences Inc (ACHV) has a market capitalisation of $ 543 Mln as on 15-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Achieve Life Sciences Inc (ACHV)?
Before investing in Achieve Life Sciences Inc (ACHV), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.